Growth Metrics

Artivion (AORT) Net Income towards Common Stockholders Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -18.72%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 13.91%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -11.74%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 98.96%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 122.60%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 89.28%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -30.10%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Artivion 1.02 Bn 961.00 Mn 75.45 Mn 380.59%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 380.59%
Dec 31, 2025 114.72%
Sep 30, 2025 384.18%
Jun 30, 2025 163.41%
Mar 31, 2025 -106.70%
Dec 31, 2024 -314.67%
Sep 30, 2024 76.66%
Jun 30, 2024 37.29%
Mar 31, 2024 155.67%
Dec 31, 2023 -283.26%
Sep 30, 2023 28.53%
Jun 30, 2023 20.59%
Mar 31, 2023 -299.29%
Dec 31, 2022 110.79%
Sep 30, 2022 -229.59%
Jun 30, 2022 -95.55%
Mar 31, 2022 -8.00%
Dec 31, 2021 -481.26%
Sep 30, 2021 468.71%
Jun 30, 2021 40.96%
Mar 31, 2021 52.92%
Dec 31, 2020 62.80%
Sep 30, 2020 -2,041.79%
Jun 30, 2020 -230.26%
Mar 31, 2020 -2,144.11%
Dec 31, 2019 -74.19%
Sep 30, 2019 -108.56%
Jun 30, 2019 1,153.10%
Mar 31, 2019 92.30%
Dec 31, 2018 42.79%
Sep 30, 2018 18.11%
Jun 30, 2018 -92.85%
Mar 31, 2018 -273.41%
Dec 31, 2017 -266.43%
Sep 30, 2017 -55.73%
Jun 30, 2017 34.77%
Mar 31, 2017 -12.51%
Dec 31, 2016 282.84%
Sep 30, 2016 39.53%
Jun 30, 2016 567.53%
Mar 31, 2016 1,027.37%
Dec 31, 2015 -272.58%
Sep 30, 2015 -7.78%
Jun 30, 2015 -123.23%
Mar 31, 2015 -125.87%
Dec 31, 2014 -81.01%
Sep 30, 2014 -26.60%
Jun 30, 2014 21.06%
Mar 31, 2014 -51.69%
Dec 31, 2013 197.37%
Sep 30, 2013 106.05%
Jun 30, 2013 -45.21%
Mar 31, 2013 121.19%
Dec 31, 2012 -614.63%
Sep 30, 2012 -23.82%
Jun 30, 2012 83.03%
Mar 31, 2012 -40.52%
Dec 31, 2011 377.24%
Sep 30, 2011 166.61%
Jun 30, 2011 -39.17%